News and blogs
384 results found.
Blood cancer drug Tepkinly authorised for use on NHS
The drug for diffuse large B-cell lymphoma, Tepkinly, has been authorised for use on the NHS as a third line treatment.
From despair to hope: The Matthew Wilson Multiple Myeloma Fund
Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.
Our response to the Government's plan for UK commercial clinical trials
Refreshing clinical trials activity must benefit people with blood cancer across the UK.
Artist Vicky Yorke shares her range of unique empathy cards
Find out more about the empathy cards created by artist Vicky Yorke, specially for Blood Cancer UK.
Insurance leader Matthew Wilson - our new chair
Matthew Wilson, Insurance leader, is set to be the new Chair of Blood Cancer UK.
Top tips for hosting a charity music event
Top tips for hosting a charity music event from supporter Ed
Amwins Global Risks partners with Blood Cancer UK to raise funds for myeloma
Blood Cancer UK are partnering with Amwins Global Risks to raise funds for myeloma
Stay updated with our organisational strategy
The latest news on our organisational strategy.
Research links childhood CT scan exposure to increased blood cancer risk
In new research, scientists have linked increased CT scan exposure to an increased risk of blood cancer in younger people.
How our research gave vaccine answers to people with blood cancer
Read about how our scientists were able to understand the effectiveness of the COVID-19 vaccine for clinically extremely vulnerable people.
The stolen legacy of Henrietta Lacks
Taken without her knowledge, Henrietta's 'immortal' cells have had an everlasting impact on research and medical ethics.
New non-Hodgkin lymphoma drug
A drug for non-Hodgkin lymphoma, epcoritamab, has been authorised for use in the UK for adults.
This MDS World Awareness Day, four people share their story
October 25 every year is World MDS Awareness Day. This year, four people share their story of living with MDS.
Zanabrutinib recommended for adults with CLL in the UK
Zanubrutinib has been recommended for adults with the blood cancer, chronic lymphocytic leukaemia (CLL) in England.
People with the blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a new treatment – glofitamab – on the NHS.
People with the blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a new treatment – glofitamab – on the NHS.
Blood Cancer UK call for UK-wide mask guidance and increased symptomatic testing
As we head into winter, Blood Cancer UK call for guidance to help protect those affected by blood cancer
What we can achieve with £1 million
We're proud to announce We’ve invested over £1 million funding five research projects, across five different blood cancers
The story of Dr Jane C Wright, pioneer of blood cancer research
To mark the start of Black History Month, we share the story of Dr Jane C Wright, a true pioneer in the field of blood cancer research
The father of the blood bank - Charles R. Drew
For Black History Month, we are celebrating Charles R. Drew who was an African American surgeon and researcher who pioneered in the field of blood transfusions, blood storage and created the first blood banks.
Ed Davey reveals experience of blood cancer
Blood Cancer UK have welcomed the Lib Dem leaders cancer pledge after he revealed insight into blood cancer experience.
